No substitute for the intravenous route

Anesthesiology

Volumn 94, Issue 1, 2001, Pages 1-2

  Donati, F ^a   Guay, J ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM;

BREATHING MUSCLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFECT; EDITORIAL; ENDOTRACHEAL INTUBATION; HUMAN; NEUROMUSCULAR BLOCKING; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL;

EID: 0035165496     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200101000-00005     Document Type: Editorial

References (10)

1. Intramuscular rapacuronium in infants and children: A comparative multicenter study to confirm the efficacy and safety of the age-related tracheal intubating doses of intramuscular rapacuronium (ORG 9487) in two groups of pediatric subjects
2. Neuromuscular blockade in infants following intramuscular succinylcholine in two or five per cent concentration
3. Dose response to intramuscular succinylcholine in children
4. Intramuscular rocuronium in infants and children: Dose ranging and tracheal intubating conditions
5. Is intramuscular mivacurium an alternative to succinylcholine?
6. Bioavailability of intramuscular rocuronium in infants and children
7. Intramuscular rocuronium in infants and children: A multicenter study to evaluate tracheal intubating conditions, onset, and duration of action
8. Intramuscular rapacuronium in infants and children: Dose-ranging and tracheal intubating conditions
9. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration
10. Femoral vascular catheterization in critically ill infants and children